+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: not found

      Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye.

      Annals of the New York Academy of Sciences

      3-Oxo-5-alpha-Steroid 4-Dehydrogenase, biosynthesis, genetics, Aging, physiology, Androgens, deficiency, Animals, Autoimmune Diseases, complications, physiopathology, Chemistry, Physical, Dry Eye Syndromes, drug therapy, etiology, Enzyme Induction, Epithelial Cells, drug effects, metabolism, Female, Humans, Lipids, secretion, Meibomian Glands, Mice, Physicochemical Phenomena, Postmenopause, RNA, Messenger, Rabbits, Receptors, Androgen, Sex Characteristics, Sjogren's Syndrome, Tears, chemistry, Testosterone, pharmacology, therapeutic use, Wettability

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          We have recently discovered that women with primary and secondary Sjögren's syndrome are androgen-deficient. We hypothesize that this hormone insufficiency contributes to the meibomian gland dysfunction, tear film instability, and evaporative dry eye that are characteristic of this autoimmune disorder. If our hypothesis is correct, we predict: (1) that androgens regulate meibomian gland function, control the quality and/or quantity of lipids produced by this tissue, and promote the formation of the tear film's lipid layer; and (2) that androgen deficiency, due to an attenuation in androgen synthesis (e.g., during Sjögren's syndrome, menopause, aging, complete androgen-insensitivity syndrome [CAIS] and anti-androgen use), will lead to meibomian gland dysfunction and evaporative dry eye. The following studies were designed to test these predictions. Experimental procedures included clinical studies, animal models, and histological, biochemical, molecular biological, and biomedical engineering techniques. Our results demonstrate that: (1) androgens regulate the meibomian gland. This tissue contains androgen receptor mRNA, androgen receptor protein within acinar epithelial cell nuclei, and Types 1 and 2 5alpha-reductase mRNAs. Moreover, androgens appear to modulate lipid production and gene expression in mouse and/or rabbit meibomian glands; and (2) androgen deficiency may lead to meibomian gland dysfunction, altered lipid profiles in meibomian gland secretions, tear film instability, and evaporative dry eye. Thus, we have found that anti-androgen therapy in men is associated with meibomian gland disease, a decreased tear film breakup time, and functional dry eye. Furthermore, we have discovered that androgen receptor dysfunction in women with CAIS is associated with meibomian gland changes and a significant increase in the signs and symptoms of dry eye. Of interest, we have also found that androgen deficiency is associated with significant and striking alterations in the neutral and polar lipid patterns of human meibomian gland secretions. Our findings show that the meibomian gland is an androgen target organ and that androgen deficiency may promote meibomian gland dysfunction and evaporative dry eye. Overall, these results support our hypothesis that androgen deficiency may be an important etiologic factor in the pathogenesis of evaporative dry eye in women with Sjögren's syndrome.

          Related collections

          Author and article information



          Comment on this article